Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Laboratories reports 18% rise in Q1 consolidated net profit

Date: 26-07-2023

Dr. Reddy's Laboratories has reported results for first quarter ended June 30, 2023 (Q1FY24). 

The company has reported over 3- fold jump in net profit at Rs 1639.40 crore for the quarter ended June 30, 2023 as compared to Rs 499.50 crore for the same quarter in the previous year. Total income of the company increased by 40.58% at Rs 5670.90 crore for Q1FY24 as compared Rs 4034.00 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 18.17% rise in its net profit at Rs 1405.00 crore for the quarter under review as compared to Rs 1189.00 crore for the same quarter in the previous year. Total income of the company increased by 13.88% at Rs 6931.90 crore for Q1FY24 as compared Rs 6086.80 crore for the corresponding quarter previous year.